Advertisement
Screener

Ernexa Therapeutics Inc. (ERNA) Increase (Decrease) in Other Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Ernexa Therapeutics Inc. Increase (Decrease) in Other Accrued Liabilities

Ernexa Therapeutics Inc. (ERNA) reported Increase (Decrease) in Other Accrued Liabilities of -$190.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-19.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2020-03-19

  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for the quarter ending 2018-12-31 was -$42.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for the quarter ending 2018-09-30 was -$49.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for the quarter ending 2018-06-30 was -$49.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for the quarter ending 2018-03-31 was -$50.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for fiscal 2018 was -$190.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for fiscal 2017 was -$189.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for fiscal 2016 was -$170.00K.
  • Ernexa Therapeutics Inc. increase (decrease) in other accrued liabilities for fiscal 2015 was -$152.00K.
Period endIncrease (Decrease) in Other Accrued Liabilities 3 monthIncrease (Decrease) in Other Accrued Liabilities 6 monthIncrease (Decrease) in Other Accrued Liabilities 9 monthIncrease (Decrease) in Other Accrued Liabilities 12 month
2018-12-31-$42.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
-$91.00K
derived: sum of 2 quarters · filed 2020-03-19
-$140.00K
derived: sum of 3 quarters · filed 2020-03-19
-$190.00K
10-K · filed 2020-03-19
2018-09-30-$49.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01
-$98.00K
derived: sum of 2 quarters · filed 2019-11-01
-$148.00K
10-Q · filed 2019-11-01
-$197.00K
derived: sum of 4 quarters · filed 2019-11-01
2018-06-30-$49.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
-$99.00K
10-Q · filed 2019-08-12
-$148.00K
derived: sum of 3 quarters · filed 2019-08-12
-$198.00K
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31-$50.00K
10-Q · filed 2019-05-14
-$99.00K
derived: sum of 2 quarters · filed 2019-05-14
-$149.00K
derived: sum of 3 quarters · filed 2019-05-14
-$194.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$49.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
-$99.00K
derived: sum of 2 quarters · filed 2019-03-22
-$144.00K
derived: sum of 3 quarters · filed 2019-03-22
-$189.00K
10-K · filed 2019-03-22
2017-09-30-$50.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$95.00K
derived: sum of 2 quarters · filed 2018-11-09
-$140.00K
10-Q · filed 2018-11-09
-$185.00K
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$45.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$90.00K
10-Q · filed 2018-08-06
-$135.00K
derived: sum of 3 quarters · filed 2018-08-06
-$179.00K
derived: sum of 4 quarters · filed 2018-08-06
2017-03-31-$45.00K
10-Q · filed 2018-05-11
-$90.00K
derived: sum of 2 quarters · filed 2018-05-11
-$134.00K
derived: sum of 3 quarters · filed 2018-05-11
-$175.00K
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31-$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
-$89.00K
derived: sum of 2 quarters · filed 2018-03-09
-$130.00K
derived: sum of 3 quarters · filed 2018-03-09
-$170.00K
10-K · filed 2018-03-09
2016-09-30-$44.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$85.00K
derived: sum of 2 quarters · filed 2017-11-08
-$125.00K
10-Q · filed 2017-11-08
-$165.00K
derived: sum of 4 quarters · filed 2017-11-08
2016-06-30-$41.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$81.00K
10-Q · filed 2017-08-04
-$121.00K
derived: sum of 3 quarters · filed 2017-08-04
-$161.00K
derived: sum of 4 quarters · filed 2017-08-04
2016-03-31-$40.00K
10-Q · filed 2017-05-04
-$80.00K
derived: sum of 2 quarters · filed 2017-05-04
-$120.00K
derived: sum of 3 quarters · filed 2017-05-04
-$156.00K
derived: sum of 4 quarters · filed 2017-05-04
2015-12-31-$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
-$80.00K
derived: sum of 2 quarters · filed 2017-03-09
-$116.00K
derived: sum of 3 quarters · filed 2017-03-09
-$152.00K
10-K · filed 2017-03-09
2015-09-30-$40.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$76.00K
derived: sum of 2 quarters · filed 2016-11-09
-$112.00K
10-Q · filed 2016-11-09
-$148.00K
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30-$36.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$72.00K
10-Q · filed 2016-08-04
-$108.00K
derived: sum of 3 quarters · filed 2016-08-04
-$144.00K
derived: sum of 4 quarters · filed 2016-08-04
2015-03-31-$36.00K
10-Q · filed 2016-05-09
-$72.00K
derived: sum of 2 quarters · filed 2016-05-09
-$108.00K
derived: sum of 3 quarters · filed 2016-05-09
-$140.00K
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31-$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$72.00K
derived: sum of 2 quarters · filed 2016-03-15
-$104.00K
derived: sum of 3 quarters · filed 2016-03-15
-$136.00K
10-K · filed 2016-03-15
2014-09-30-$36.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$68.00K
derived: sum of 2 quarters · filed 2015-11-09
-$100.00K
10-Q · filed 2015-11-09
-$132.00K
derived: sum of 4 quarters · filed 2015-11-09
2014-06-30-$32.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$64.00K
10-Q · filed 2015-08-10
-$96.00K
derived: sum of 3 quarters · filed 2015-08-10
-$128.00K
derived: sum of 4 quarters · filed 2015-08-10
2014-03-31-$32.00K
10-Q · filed 2015-05-08
-$64.00K
derived: sum of 2 quarters · filed 2015-05-08
-$96.00K
derived: sum of 3 quarters · filed 2015-05-08
-$125.00K
derived: sum of 4 quarters · filed 2015-05-08
2013-12-31-$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27
-$64.00K
derived: sum of 2 quarters · filed 2015-03-27
-$93.00K
derived: sum of 3 quarters · filed 2015-03-27
-$120.00K
10-K · filed 2015-03-27
2013-09-30-$32.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$61.00K
derived: sum of 2 quarters · filed 2014-11-07
-$88.00K
10-Q · filed 2014-11-07
-$115.00K
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30-$29.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$56.00K
10-Q · filed 2014-08-14
-$83.00K
derived: sum of 3 quarters · filed 2014-08-14
-$74.00K
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31-$27.00K
10-Q · filed 2014-05-15
-$54.00K
derived: sum of 2 quarters · filed 2014-05-15
-$45.00K
derived: sum of 3 quarters · filed 2014-05-15
$55.00K
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31-$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$18.00K
derived: sum of 2 quarters · filed 2014-03-31
$82.00K
derived: sum of 3 quarters · filed 2014-03-31
$193.00K
10-K · filed 2014-03-31
2012-09-30$9.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
$109.00K
derived: sum of 2 quarters · filed 2013-11-14
$220.00K
10-Q · filed 2013-11-14
$331.00K
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$211.00K
10-Q · filed 2013-08-14
$322.00K
derived: sum of 3 quarters · filed 2013-08-14
$399.00K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$111.00K
10-Q · filed 2013-05-13
$222.00K
derived: sum of 2 quarters · filed 2013-05-13
$299.00K
derived: sum of 3 quarters · filed 2013-05-13
2011-12-31$111.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29
$188.00K
derived: sum of 2 quarters · filed 2013-03-29
$187.00K
10-K · filed 2013-03-29
2011-09-30$77.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$76.00K
10-Q · filed 2012-11-09
2011-06-30-$1.00K
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pulmatrix, Inc. (PULM)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
SYNLOGIC, INC. (SYBX)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B